CLINICAL_TRIALS
trial_result
· 2018-11-19
Clinical Trial Update: A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Summary
Clinical trial update for LY2090314 with chemotherapy in metastatic pancreatic cancer (Phase 1/2) terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-11-19